Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasoreactivity and endogenous NO production in coronary bypass grafts after CABG
2006-000353-21Phase 2Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- May 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of substance p in coronary arteriosclerosis, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Endogenous nitric oxide production by each graft. Started May 2006; status: completed.
02
Drugs
substance p
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-000353-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000353-21.